| Laura Celeste Black, MD | |
|
336 N Main St, West Hartford, CT 06117 | |
| (860) 232-4891 | |
| (860) 236-1016 |
| Full Name | Laura Celeste Black |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 336 N Main St, West Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124388129 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD14897 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Inc | 1153573902 | 221 |
News Archive
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.
Planned Parenthood of Wisconsin has stopped giving non-surgical abortions after a new law took effect that requires women to have three doctor visits before getting a drug-induced abortion. In Iowa, Planned Parenthood of the Heartland is criticizing the state budget that would disallow public Medicaid funding for abortions in cases of rape or incest.
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear™ 3-4 and Linear™ 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. The Company plans to launch the products immediately in the U.S.; they were launched in Europe and other international markets earlier.
Researchers in Doernbecher Children's Hospital at Oregon Health & Science University will begin a Phase I clinical trial using stem cells in infants and children with a rare neurodegenerative disorder that affects infants and children.
› Verified 2 days ago
| Entity Name | Hartford Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043561301 PECOS PAC ID: 1153573902 Enrollment ID: O20121201000007 |
News Archive
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.
Planned Parenthood of Wisconsin has stopped giving non-surgical abortions after a new law took effect that requires women to have three doctor visits before getting a drug-induced abortion. In Iowa, Planned Parenthood of the Heartland is criticizing the state budget that would disallow public Medicaid funding for abortions in cases of rape or incest.
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear™ 3-4 and Linear™ 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. The Company plans to launch the products immediately in the U.S.; they were launched in Europe and other international markets earlier.
Researchers in Doernbecher Children's Hospital at Oregon Health & Science University will begin a Phase I clinical trial using stem cells in infants and children with a rare neurodegenerative disorder that affects infants and children.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Celeste Black, MD 17 Virginia Ave, Suite 107, Providence, RI 02905-4406 Ph: (401) 443-4992 | Laura Celeste Black, MD 336 N Main St, West Hartford, CT 06117 Ph: (860) 232-4891 |
News Archive
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.
Planned Parenthood of Wisconsin has stopped giving non-surgical abortions after a new law took effect that requires women to have three doctor visits before getting a drug-induced abortion. In Iowa, Planned Parenthood of the Heartland is criticizing the state budget that would disallow public Medicaid funding for abortions in cases of rape or incest.
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear™ 3-4 and Linear™ 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. The Company plans to launch the products immediately in the U.S.; they were launched in Europe and other international markets earlier.
Researchers in Doernbecher Children's Hospital at Oregon Health & Science University will begin a Phase I clinical trial using stem cells in infants and children with a rare neurodegenerative disorder that affects infants and children.
› Verified 2 days ago
Dr. Varalakshmi Niranjan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 Kane St, West Hartford, CT 06119 Phone: 860-523-6436 Fax: 860-523-3775 | |
Dr. Gregory C Walsh, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 20 Isham Rd, Suite 150, West Hartford, CT 06107 Phone: 860-527-1669 Fax: 860-293-0783 | |
Myra Rosenstein, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 65 Kane St, Internal Medicine, West Hartford, CT 06119 Phone: 860-523-6436 Fax: 860-523-3775 | |
Dr. William James Pickering, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1064 Farmington Ave, West Hartford, CT 06107 Phone: 860-561-3890 Fax: 860-521-8040 | |
Dr. Pallavi Lakra, Internal Medicine Medicare: Medicare Enrolled Practice Location: 336 N Main St, West Hartford, CT 06117 Phone: 860-232-4891 | |
John Papandrea, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 N Main St, Suite 300, West Hartford, CT 06107 Phone: 860-313-0448 Fax: 860-313-1464 | |
Donald S Ruffett, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 345 N Main St Fl 1, West Hartford, CT 06117 Phone: 860-547-1489 Fax: 860-548-9105 |